Covid-19 plot twist: China claims virus may have emerged from the US

The US not only botched its own response to Covid-19; it also obstructed and sabotaged international cooperation in various ways, allege a white paper released by China

JN.1, JN.1 covid, covid
US research suggests that from all perspectives, the Covid-19 outbreak could not be from a natural origin like other viruses in the past. (Photo: Freepik)
Md Zakariya Khan New Delhi
3 min read Last Updated : May 01 2025 | 5:23 PM IST

Don't want to miss the best from Business Standard?

China has pushed back against US allegations suggesting the Covid-19 virus may have originated in the US, following repeated accusations from the Trump administration that the virus outbreak began in the Chinese city of Wuhan.
 
China released a white paper titled ‘Covid-19 Prevention, Control and Origins Tracing: China’s Actions and Stance’ on Wednesday (local time), presenting its case that Covid-19 virus may have originated in the US and its government has “tried to shift the blame” and divert people’s attention by “shamelessly politicising SARS-CoV-2 origins tracing”.
 
“Substantial evidence suggests that Covid-19 might have emerged in the United States earlier than its officially claimed timeline, and earlier than the outbreak in China,” the whitepaper mentioned.
 
 China blames US for pandemic
 
Choosing to downplay the severity of the epidemic, the US government on multiple occasions compared Covid-19 to the flu, saying that it would disappear automatically one day, it said. “The US not only botched its own response to Covid-19; it also obstructed and sabotaged international cooperation in various ways. The deliberate concealment of information by the US government misled other countries and the WHO in the research and analysis of Covid-19 trend,” the report reads. 
 
The report said China shared important information with the World Health Organization (WHO) and other countries on time. It pointed out that a joint investigation by China and the WHO found that a lab leak was “extremely unlikely”. China alleged the US should stop ignoring international concerns and respond honestly to them.
 
 China counters US lab-leak narrative
 
The whitepaper is seen as a response to the recently launched (April 18, 2025) US website ‘Lab Leak: The True Origins of Covid-19’ documenting the evidence that Covid-19 was not a natural calamity but a human-made disaster.
 
“The virus possesses a biological characteristic that is not found in nature. Data shows that all Covid-19 cases stem from a single introduction into humans. This runs contrary to previous pandemics where there were multiple spillover events,” the website reads. The US criticised China for conducting multiple research projects that pose a risk to human life.  
 
 US links Wuhan lab to outbreak
 
“Wuhan is home to China’s foremost SARS research lab, which has a history of conducting gain-of-function research (gene altering and organism supercharging) at inadequate biosafety levels. Wuhan Institute of Virology (WIV) researchers were sick with Covid-like symptoms in the fall of 2019, months before Covid-19 was discovered at the wet market,” the website mentions.
 
US research suggests that from all perspectives, the Covid-19 outbreak could not be from a natural origin like other viruses in the past. “By nearly all measures of science, if there was evidence of a natural origin, it would have already surfaced. But it hasn’t,” it reads.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDonald TrumpCoronavirus VaccineUS President Donald TrumpChinese governmentBS Web Reports

First Published: May 01 2025 | 5:22 PM IST

Next Story